Pembrolizumab and Olaparib in Homologous-recombination Deficient (HRD) Advanced Colorectal Cancer (CRC).
Conditions
- Metastatic Colorectal Cancer
Interventions
- DRUG: Olaparib
- DRUG: Pembrolizumab
Sponsor
Grupo Espanol Multidisciplinario del Cancer Digestivo
Collaborators